Results 301 to 310 of about 98,638 (334)

Investigating Potential Cancer Therapeutics: Insight into Histone Deacetylases (HDACs) Inhibitions. [PDF]

open access: yesPharmaceuticals (Basel)
Ahmad B   +8 more
europepmc   +1 more source

Hypoxia and the cytoskeleton

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Schematic outlining the activation of hypoxia‐sensitive pathways, the influence of hypoxia and associated pathways on the cytoskeleton, and the impact of these on disease progression. Abstract A highly‐regulated and dynamic cytoskeleton is vital for functional cellular physiology and the maintenance of homeostasis.
Darragh Flood, Cormac T. Taylor
wiley   +1 more source

Epigenetic and Metabolic Reprogramming of Fibroblasts in Crohn's Disease Strictures Reveals Histone Deacetylases as Therapeutic Targets. [PDF]

open access: yesJ Crohns Colitis
Lewis A   +21 more
europepmc   +1 more source

Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas. [PDF]

open access: yesElife
Algranati D   +10 more
europepmc   +1 more source

Histone deacetylases

Current Opinion in Pharmacology, 2003
Post-translational modification of the histones of chromatin has a fundamental role in regulating gene expression. Enzymes involved in these epigenetic events include histone deacetylases (class I and class II), which can be inhibited by a structurally diverse group of small molecules.
Paul A, Marks   +2 more
openaire   +2 more sources

Histone Deacetylase Inhibitors

ChemInform, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
Thomas A, Miller   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy